Nallely Michelle Panduro-López

Ms. Nallely Michelle Panduro-López

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2026 in Aquaculture Journal
Verified
Journal Article
Open access
PDF file
GLGerman Leon
German Leon
José Antonio JAEG Estrada-GodinezJosé Antonio JAEG Estrada-Godinez
José Antonio JAEG Estrada-Godinez
GCGabriela López Cervantes
Gabriela López Cervantes
PRPindaro Álvarez Ruiz
Pindaro Álvarez Ruiz
FFFrancisco Antonio Flores-Higuera
Francisco Antonio Flores-Higuera
MMMagnolia Montoya-Mejia
Magnolia Montoya-Mejia
This study evaluated the effects of dietary folic acid supplementation on growth performance, antioxidant- and immune-related gene expression, and the response to acute hepatopancreatic necrosis disease (AHPND) in Pacific white shrimp (Penaeus vannamei). Juveniles (12 shrimp per tank; four replicate tanks per treatment) were fed diets containing nominal supplemental folic acid levels of 0, 2, 5, or 10 mg kg−1 for 35 days, and 30 shrimp per dietary treatment (three replicate aquaria; 10 shrimp per aquarium) were subsequently challenged with an AHPND-causing strain of Vibrio parahaemolyticus. Among the supplementation levels evaluated, the 5 mg kg−1 diet produced the highest final weight (14.8 ± 0.5 g), weight gain (7.9 ± 0.3 g), a specific growth rate (2.14 ± 0.1% day−1), and the lowest apparent feed conversion ratio (1.3 ± 0.1), whereas the Control showed values of 12.3 ± 0.7 g, 5.4 ± 0.3 g, 1.6 ± 0.1% day−1, and 1.6 ± 0.1, respectively (p ≤ 0.05). Dietary folic acid modulated the relative expression of antioxidant-related genes (SOD, CAT, and GPX) in the gills and hepatopancreas and altered basal and post-challenge expression of the immune-related genes ALFP, CTL3, GILT, MNK, and SR in the gills. At 72 h post-challenge, final cumulative mortality differed among treatments (F3,8 = 5.405, p = 0.025), with lower mortality in T5 (36.7 ± 7.6%) than in the Control (53.3 ± 2.9%; Tukey, p = 0.022). These findings indicate that dietary folic acid supplementation influenced growth performance, challenge outcomes, and transcriptional responses in juvenile Penaeus vannamei. Among the supplementation levels evaluated, the 5 mg kg−1 diet consistently produced the most favorable combination of growth performance, lower final challenge mortality, and modulation of antioxidant- and immune-related gene expression.

2 October 2026 in Aquaculture Journal
Verified
Journal Article
Open access
PDF file
Nallely Michelle Panduro-LópezNallely Michelle Panduro-López
Nallely Michelle Panduro-López
PRPindaro Álvarez Ruiz
Pindaro Álvarez Ruiz
MMMagnolia Montoya-Mejia
Magnolia Montoya-Mejia
Hervey Rodriguez-GonzalezHervey Rodriguez-Gonzalez
Hervey Rodriguez-Gonzalez
CJCarina Gámez Jiménez
Carina Gámez Jiménez
DBDiana Laura Báez-Moreno
Diana Laura Báez-Moreno
This study characterized acid hydrolysates prepared from WSSV-infected (HS-WSSV) and non-infected (HS-noWSSV) Penaeus (Litopenaeus) vannamei Boone, 1931 muscle and evaluated immune-related transcript abundance and survival following WSSV challenge. Hydrolysates were maintained at pH 3.8 for 20 d, and their soluble protein profiles were assessed by SDS-PAGE. Shrimp received selected hydrolysate supernatants by intramuscular injection, and transcript abundance of Dorsal, Relish, Rab6, proPO, and PAP was evaluated at 3, 6, and 12 h post-injection. Survival was assessed after intramuscular and short-term immersion WSSV challenges. SDS-PAGE showed progressive changes in banding patterns consistent with protein degradation and distinct soluble protein profiles between HS-WSSV and HS-noWSSV preparations. Significant differences between HS-WSSV and the corresponding HS-noWSSV preparations were detected for several immune-related transcripts at specific hydrolysis and sampling times (p ≤ 0.05). Survival was evaluated using Kaplan–Meier analysis and Cox proportional hazards models with aquarium-clustered robust standard errors. In the intramuscular challenge, the 10 d HS-WSSV treatment showed the highest final survival (40.0%) and a lower mortality hazard than the WSSV-positive control (HR = 0.624, 95% CI: 0.349–1.115), although this difference was not significant (p = 0.112). In the short-term immersion challenge, the 10 d preparation produced the highest final survival (56.7%) and a significantly lower mortality hazard (HR = 0.472, 95% CI: 0.367–0.608, p < 0.001). Under the evaluated conditions, the 10 d HS-WSSV preparation was associated with early transcript-abundance changes and the most favorable survival profile, particularly following short-term immersion challenge.